Company profile
Keratify
Keratify. The new ex vivo skin testing platform, developing new types of 3D skin models.
Financial period: 1 Jul 2024 to 30 Jun 2025
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
1 Jul 2024 to 30 Sep 2024
The skin is the largest organ of the human body and all compounds, whether they are used for therapeutic purposes, as a cosmetic and consumer good or in other applications such as a pesticide, must be tested in the laboratory to ensure they are safe. The skin is a fascinating organ in that it can metabolise drugs similar to the liver. While the liver is t...
1 Jun 2020 to 31 Jan 2021
no public description
1 Nov 2019 to 31 Jan 2021
The skin is the protective outer layer of the body. It is effective in preventing damage from a range of biological and environmental agents during its lifetime including pathogens, UV radiation and pollution. Despite its effectiveness in this task, the skin requires the application of topical agents to enhance and improve its function. One such product a...
